Live feed
Filing
SC 13D/A
SC 13D/A0001493152-24-049162·PROVECTUS BIOPHARMACEUTICALS, INC.
Schedule 13D ownership disclosure
PROVECTUS PHARMACEUTICAL INCORPORATED
Security class unavailable · CUSIP: 74373P108
Event date: 2024-12-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.0300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-24-049162
- Form type
- SC 13D/A
- Filer
- PROVECTUS BIOPHARMACEUTICALS, INC.
- CIK
- CIK 315545
- Filed
- Dec 06, 2024
- Reporting period
- Dec 02, 2024
- Description
- Schedule 13D beneficial ownership